1.The Effectiveness of Multidisciplinary Team-Based Education in the Management of Type 2 Diabetes.
Jong Ho KIM ; Yun Jeong NAM ; Won Jin KIM ; Kyung Ah LEE ; A Ran BAEK ; Jung Nam PARK ; Jin Mi KIM ; Seo Young OH ; Eun Heui KIM ; Min Jin LEE ; Yun Kyung JEON ; Bo Hyun KIM ; In Joo KIM ; Yong Ki KIM ; Sang Soo KIM
Journal of Korean Diabetes 2018;19(2):119-133
BACKGROUND: Although clinicians, nurse specialists, pharmacists, and nutritionists expend significant time and resources in optimizing care for patients with diabetes, the effectiveness of integrated diabetes care team approach remains unclear. We assessed the effects of a multidisciplinary team care educational intervention on glycated hemoglobin (HbA1c) levels among diabetes patients. METHODS: We conducted a matched case-control study in Korean patients with type 2 diabetes, comparing the propensity scores pertaining to the effectiveness in reducing HbA1c levels between a group receiving an educational intervention and a control group. We included 40 pairs of patients hospitalized between June 2014 and September 2016. HbA1c values measured at baseline, 3 months, and 6 months were compared between the two groups. RESULTS: The educated group showed an improvement in HbA1c levels compared to the control group at 3 months (6.3 ± 2.3% vs. 9.5 ± 4.0%; P = 0.020) and at 6 months (7.5 ± 1.5% vs. 9.6 ± 3.0%; P = 0.106). There was a significant difference in the change in mean HbA1c from baseline to 3 months between the two groups (−35.7 ± 26.1% vs. −9.1 ± 20.5%; P = 0.013). CONCLUSION: A multidisciplinary team care education intervention was advantageous for improving glucose control in patients with type 2 diabetes, and may help to optimize glycemic control in clinical practice.
Case-Control Studies
;
Diabetes Mellitus
;
Education*
;
Glucose
;
Health Education
;
Hemoglobin A, Glycosylated
;
Humans
;
Nurse Clinicians
;
Nutritionists
;
Pharmacists
;
Propensity Score
;
Specialization
2.Prevalence of BRAF(V600E) Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAF(V600E) Prevalent Area.
Hyereen KIM ; Bo Hyun KIM ; Young Keum KIM ; Jeong Mi KIM ; Seo Young OH ; Eun Heui KIM ; Min Jin LEE ; Jong Ho KIM ; Yun Kyung JEON ; Sang Soo KIM ; Byung Joo LEE ; Yong Ki KIM ; In Joo KIM
Journal of Korean Medical Science 2018;33(27):e75-
BACKGROUND: BRAF V600E mutation status and prevalence of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) has not yet been reported in Korea. The aim of this study was to investigate the significance of the BRAF V600E mutation in the follicular variant of papillary thyroid carcinoma (FVPTC) and to determine the prevalence of NIFTP in BRAF V600E mutation-prevalent Korean patients. METHODS: This study retrospectively analyzed 1,417 consecutive patients who underwent total thyroidectomy with routine prophylactic central lymph node dissection for papillary thyroid carcinoma (PTC). BRAF V600E mutation analysis was performed routinely using multiplex polymerase chain reaction by applying dual priming oligonucleotide. Clinicopathological characteristics and ultrasonographic findings were compared between BRAF V600E mutation-positive and -negative groups for FVPTC. Pathologists reviewed the pathology slides according to consensus diagnostic criteria for the encapsulated FVPTC and NIFTP. RESULTS: The prevalence of the BRAF V600E mutation in all subtypes of PTC was 61.0% (861/1,411). FVPTC presented a BRAF V600E mutation rate of 27.3%. The FVPTC patients with BRAF V600E mutation were older than those with no BRAF V600E mutation (P = 0.021). The prevalence of NIFTP was 0.18% among all PTC patients (2/1,411) and the proportion of NIFTP among FVPTC was 9.1% (2/22). CONCLUSION: The BRAF V600E mutation is prevalent in Korean patients with FVPTC in a region with high frequency of the BRAF V600E mutation and very low prevalence of NIFTP compared with that reported in western studies.
Carcinoma, Papillary
;
Consensus
;
Humans
;
Korea
;
Lymph Node Excision
;
Multiplex Polymerase Chain Reaction
;
Mutation Rate
;
Pathology
;
Prevalence*
;
Retrospective Studies
;
Thyroid Gland*
;
Thyroid Neoplasms*
;
Thyroidectomy
3.Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
Min Jin LEE ; Sang Soo KIM ; In Joo KIM ; Sang Heon SONG ; Eun Heui KIM ; Ji Yeong SEO ; Jong Ho KIM ; Sungsu KIM ; Yun Kyung JEON ; Bo Hyun KIM ; Yong Ki KIM
Journal of Korean Medical Science 2017;32(5):782-788
Urinary angiotensinogen (AGT) is potentially a specific biomarker for the status of the intrarenal renin-angiotensin system (RAS) in patients with diabetes mellitus. We explored whether changes in urinary AGT excretion levels were associated with the deterioration of kidney function in type 2 diabetes patients with preserved kidney function. Urinary baseline AGT levels were measured in 118 type 2 diabetic patients who were not taking RAS blockers and who had estimated glomerular filtration rates (eGFRs) ≥ 60 mL/min/1.73 m². A total of 91 patients were followed-up for 52 months. Changes in urinary levels of AGT (ΔAGT) were calculated by subtracting urinary AGT/creatinine (Cr) at baseline from urinary AGT/Cr after 1 year. ΔAGT was significantly inversely correlated with annual eGFR change (β = −0.29, P = 0.006; β = −0.37, P = 0.001 after adjusting for clinical factors). RAS blockers were prescribed in 36.3% of patients (n = 33) during follow-up. The ΔAGT values were lower in the RAS blockers users than in the non-RAS blockers users, but the differences were not statistically significant (7.37 ± 75.88 vs. 22.55 ± 57.45 μg/g Cr, P = 0.081). The ΔAGT values remained significantly correlated with the annual rate of eGFR change (β = −0.41, P = 0.001) in the patients who did not use RAS blockers, but no such correlation was evident in the patients who did. ΔAGT is inversely correlated with annual changes in eGFR in type 2 diabetes patients with preserved kidney function, particularly in RAS blocker-naïve patients.
Angiotensinogen*
;
Diabetes Mellitus
;
Diabetes Mellitus, Type 2*
;
Diabetic Nephropathies
;
Follow-Up Studies
;
Glomerular Filtration Rate
;
Humans
;
Kidney*
;
Renin-Angiotensin System
4.Clinical Evaluation of Rapid Diagnostic Test Kit for Scrub Typhus with Improved Performance.
Young Jin KIM ; Sungman PARK ; Ranjan PREMARATNA ; Stephen SELVARAJ ; Sang Jin PARK ; Sora KIM ; Donghwan KIM ; Min Soo KIM ; Dong Hoon SHIN ; Kyung Chan CHOI ; Soon Hwan KWON ; Wonjun SEO ; Nam Taek LEE ; Seung Han KIM ; Heui Keun KANG ; Yoon Won KIM
Journal of Korean Medical Science 2016;31(8):1190-1196
Diagnosis of scrub typhus is challenging due to its more than twenty serotypes and the similar clinical symptoms with other acute febrile illnesses including leptospirosis, murine typhus and hemorrhagic fever with renal syndrome. Accuracy and rapidity of a diagnostic test to Orientia tsutsugamushi is an important step to diagnose this disease. To discriminate scrub typhus from other diseases, the improved ImmuneMed Scrub Typhus Rapid Diagnostic Test (RDT) was evaluated in Korea and Sri Lanka. The sensitivity at the base of each IgM and IgG indirect immunofluorescent assay (IFA) in Korean patients was 98.6% and 97.1%, and the specificity was 98.2% and 97.7% respectively. The sensitivity and specificity for retrospective diagnosis at the base of IFA in Sri Lanka was 92.1% and 96.1%. ImmuneMed RDT was not reactive to any serum from seventeen diseases including hemorrhagic fever with renal syndrome (n = 48), leptospirosis (n = 23), and murine typhus (n = 48). ImmuneMed RDT shows superior sensitivity (98.6% and 97.1%) compared with SD Bioline RDT (84.4% at IgM and 83.3% at IgG) in Korea. The retrospective diagnosis of ImmuneMed RDT exhibits 94.0% identity with enzyme-linked Immunosorbent assay (ELISA) using South India patient serum samples. These results suggest that this RDT can replace other diagnostic tests and is applicable for global diagnosis of scrub typhus. This rapid and accurate diagnosis will be beneficial for diagnosing and managing scrub typhus.
Antibodies, Bacterial/blood
;
Enzyme-Linked Immunosorbent Assay
;
Fluorescent Antibody Technique, Indirect
;
Humans
;
Immunoglobulin G/blood
;
Immunoglobulin M/blood
;
Orientia tsutsugamushi/immunology
;
Reagent Kits, Diagnostic
;
Retrospective Studies
;
Scrub Typhus/*diagnosis/microbiology
;
Sensitivity and Specificity
5.Optimal hemoglobin level for anemia treatment in a cohort of hemodialysis patients.
Mi Yeon JUNG ; Soon Young HWANG ; Yu Ah HONG ; Su Young OH ; Jae Hee SEO ; Young Mo LEE ; Sang Won PARK ; Jung Sun KIM ; Joon Kwang WANG ; Jeong Yup KIM ; Ji Eun LEE ; Gang Jee KO ; Heui Jung PYO ; Young Joo KWON
Kidney Research and Clinical Practice 2015;34(1):20-27
BACKGROUND: Anemia is a major risk factor that contributes to mortality in patients with chronic kidney disease. There is controversy over the optimal hemoglobin (Hb) target in these patients. This study investigated the association between Hb level and mortality in a cohort of hemodialysis (HD) patients in Korea. METHODS: This study was a multicenter prospective observational study of maintenance HD patients that was performed for 5 years in western Seoul, Korea. Three hundred and sixty-two participants were enrolled. Laboratory values and mortality were accessed every 6 months. Repeated measures of laboratory values in each interval were averaged to obtain one semiannual mean value. The Hb values were divided into six groups: (1) Hb<9 g/dL; (2) 9 g/dL< or =Hb<10 g/dL; (3) 10 g/dL< or =Hb<11 g/dL; (4) 11 g/dL< or =Hb<12 g/dL; (5) 12 g/dL< or =Hb<13 g/dL; and (6) Hb> or =13 g/dL. We analyzed the odds ratio for all-cause mortality, based on the Hb group, and adjusted for demographics and various laboratory values. Statistics were performed with SAS, version 9.1 software (SAS Institute Inc., Cary, NC, USA). RESULTS: Mortality odds ratios relative to the reference group (10-11 g/dL) in the fully adjusted model were 3.61 for<9 g/dL; 3.17 for 9-10 g/dL*; 4.65 for 11-12 g/dL*; 5.50 for 12-13 g/dL*; and 2.05 for> or =13 g/dL (* indicates P<0.05). CONCLUSION: In this study, a Hb level of 10-11 g/dL was associated with the lowest mortality among the groups with Hb level<13 g/dL. Larger interventional trials are warranted to determine the optimal Hb target for Korean HD patients.
Anemia*
;
Cohort Studies*
;
Demography
;
Humans
;
Korea
;
Mortality
;
Observational Study
;
Odds Ratio
;
Prospective Studies
;
Renal Dialysis*
;
Renal Insufficiency, Chronic
;
Risk Factors
;
Seoul
6.Association between Promoter Polymorphisms of TFF1, TFF2, and TFF3 and the Risk of Gastric and Diffuse Gastric Cancers in a Korean Population.
Eun Heui JIN ; Sang Il LEE ; Jaewoo KIM ; Eun Young SEO ; Su Yel LEE ; Gang Min HUR ; Sanghee SHIN ; Jang Hee HONG
Journal of Korean Medical Science 2015;30(8):1035-1041
Gastric cancer is one of the most common cancers in the world. The aims of this study were to evaluate the association between polymorphisms in TFF gene family, TFF1, TFF2, and TFF3 and the risk of gastric cancer (GC) and GC subgroups in a Korean population via a case-control study. The eight polymorphisms in TFF gene family were identified by sequencing and genotyped with 377 GC patients and 396 controls by using TaqMan genotyping assay. The rs184432 TT genotype of TFF1 was significantly associated with a reduced risk of GC (odds ratio, [OR) = 0.45; 95% confidence interval, [CI] = 0.25-0.82; P = 0.009), more protective against diffuse-type GC (OR = 0.20; 95% CI = 0.05-0.89; P = 0.035) than GC (OR = 0.34; 95% CI = 0.14-0.82; P = 0.017) in subjects aged < 60 yr, and correlated with lymph node metastasis negative GC and diffuse-type GC (OR = 0.44; 95% CI = 0.23-0.86; P = 0.016 and OR = 0.20; 95% CI = 0.05-0.87; P = 0.031, respectively). In addition, a decreased risk of lymph node metastasis negative GC and diffuse-type GC was observed for rs225359 TT genotype of TFF1 (OR = 0.46, 95% CI = 0.24-0.88; P = 0.020 and OR = 0.21, 95% CI = 0.05-0.88; P = 0.033, respectively). These findings suggest that the rs184432 and rs225359 polymorphisms in TFF1 have protective effects for GC and contribute to the development of GC in Korean individuals.
Adult
;
Aged
;
Biomarkers, Tumor/*genetics
;
Female
;
Genetic Markers/genetics
;
Genetic Predisposition to Disease/epidemiology/genetics
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Peptides/*genetics
;
Polymorphism, Single Nucleotide/genetics
;
Promoter Regions, Genetic/genetics
;
Reproducibility of Results
;
Republic of Korea/epidemiology
;
Risk Assessment/methods
;
Sensitivity and Specificity
;
Stomach Neoplasms/*epidemiology/*genetics
;
Tumor Suppressor Proteins/*genetics
7.Clinical Characteristics of a Nationwide Hospital-based Registry of Mild-to-Moderate Alzheimer's Disease Patients in Korea: A CREDOS (Clinical Research Center for Dementia of South Korea) Study.
Hee Kyung PARK ; Duk L NA ; Seol Heui HAN ; Ji Young KIM ; Hae Kwan CHEONG ; Seong Yoon KIM ; Sang Yun KIM ; Chang Hyung HONG ; Do Kwan KIM ; Bon D KU ; So Young MOON ; Jun Young LEE ; Yong S SHIM ; Young Chul YOUN ; Eun Joo KIM ; Beoung Chae KIM ; Kee Hyung PARK ; Kyung R CHA ; Sang Won SEO ; Jae Hong LEE
Journal of Korean Medical Science 2011;26(9):1219-1226
With rapid population aging, the socioeconomic burden caused by dementia care is snowballing. Although a few community-based studies of Alzheimer's disease (AD) have been performed in Korea, there has never been a nationwide hospital-based study thereof. We aimed to identify the demographics and clinical characteristics of mild-to-moderate AD patients from the Clinical Research Center for Dementia of Korea (CREDOS) registry. A total of 1,786 patients were consecutively included from September 2005 to June 2010. Each patient underwent comprehensive neurological examination, interview for caregivers, laboratory investigations, neuropsychological tests, and brain MRI. The mean age was 74.0 yr and the female percentage 67.0%. The mean period of education was 7.1 yr and the frequency of early-onset AD (< 65 yr old) was 18.8%. Among the vascular risk factors, hypertension (48.9%) and diabetes mellitus (22.3%) were the most frequent. The mean score of the Korean version of Mini-Mental State Examination (K-MMSE) was 19.2 and the mean sum of box scores of Clinical Dementia Rating (CDR-SB) 5.1. Based on the well-structured, nationwide, and hospital-based registry, this study provides the unique clinical characteristics of AD and emphasizes the importance of vascular factors in AD in Korea.
Aged
;
Aged, 80 and over
;
Alzheimer Disease/complications/*diagnosis
;
Brain/radionuclide imaging
;
Caregivers
;
Dementia/diagnosis
;
Demography
;
Diabetes Mellitus, Type 2/etiology
;
Female
;
Hospitals
;
Humans
;
Hypertension/etiology
;
Interviews as Topic
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Questionnaires
;
*Registries
;
Republic of Korea
;
Risk Factors
8.Pure Word Deafness in a Patient with Early-Onset Alzheimer's Disease: An Unusual Presentation.
Sook Hui KIM ; Mee Kyung SUH ; Sang Won SEO ; Juhee CHIN ; Seol Heui HAN ; Duk L NA
Journal of Clinical Neurology 2011;7(4):227-230
BACKGROUND AND PURPOSE: The occurrence of PWD in neurodegenerative disease is very rare, and this is the first report of it being related to early-onset AD. We describe a patient with early-onset Alzheimer's disease (AD) who presented with pure word deafness (PWD). CASE REPORT: The patient had experienced PWD for 2 years, followed by other cognitive deficits suggestive of parietotemporal dysfunction. Brain imaging including 18FDG-PET and [11C] PIB-PET supported the diagnosis of AD. CONCLUSIONS: Our case highlights the clinical variability that characterizes early-onset AD.
Alzheimer Disease
;
Aphasia, Primary Progressive
;
Deafness
;
Humans
;
Neurodegenerative Diseases
;
Neuroimaging
9.Clinical practice guideline for dementia by Clinical Research Center for Dementia of South Korea.
Bon D KU ; Shin Gyeom KIM ; Jun Young LEE ; Kee Hyung PARK ; Joon Hyun SHIN ; Kwang Ki KIM ; Young Chul YOUN ; Yung Min LEE ; Chang Hyung HONG ; Sang Won SEO ; Duk L NA ; Sung Yoon KIM ; Hae Kwan CHEONG ; Doh Kwan KIM ; Jae Hong LEE ; Sang Yun KIM ; Byeong Kil YEON ; Soo Young KIM ; Seol Heui HAN
Journal of the Korean Medical Association 2011;54(8):861-875
The Clinical Research Center for Dementia of South Korea (CREDOS), a nation-wide clinical dementia research group, has prepared clinical practice guidelines (CPG) for dementia tailored to the Korean population. In this article, a summary of the CREDOS CPG is presented with the Korean and English version of full report included in the appendix. The CREDOS CPG in intended not only for psychiatrists and neurologists, but also internists, family physicians, and other primary care physicians involved in the prevention and early diagnosis of dementia. While our CPG for dementia mainly covers Alzheimer's disease (AD) and vascular dementia (VaD), it also includes mild cognitive impairment (MCI) and vascular MCI, which are currently known to be the preclinical stages of AD or VaD, respectively, with emphasis placed on early diagnosis. The CREDOS CPG aims to achieve the following goals by developing CPG for dementia: to establish evidence-based, objective and clear clinical standards for dementia; to improve the clinical decision-making process for patients with dementia; to provide scientific and systematic scales to aid in the work of dementia specialists; to suggest comprehensive and systematic healthcare services tailored to each dementia subtype. The CREDOS CPG focuses on diagnosis and evaluation of clinical practice available domestically, and provides useful concepts of dementia. Its emphasis is on etiologies and epidemiology, diagnostic criteria and evaluation, neuropsychological tests, behavioral and psychological symptoms, the activities of daily living, laboratory tests, and brain imaging.
Activities of Daily Living
;
Alzheimer Disease
;
Appendix
;
Delivery of Health Care
;
Dementia
;
Dementia, Vascular
;
Early Diagnosis
;
Humans
;
Mild Cognitive Impairment
;
Neuroimaging
;
Neuropsychological Tests
;
Physicians, Family
;
Physicians, Primary Care
;
Psychiatry
;
Republic of Korea
;
Weights and Measures
10.Hyperosmotic Stimulus Down-regulates 1alpha, 25-dihydroxyvitamin D3-induced Osteoclastogenesis by Suppressing the RANKL Expression in a Co-culture System.
Yu Shun TIAN ; Hyun Joo JEONG ; Sang Do LEE ; Seok Heui KONG ; Seung Ho OHK ; Yun Jung YOO ; Jeong Taeg SEO ; Dong Min SHIN ; Byung Wha SOHN ; Syng Ill LEE
The Korean Journal of Physiology and Pharmacology 2010;14(3):169-176
The hyperosmotic stimulus is regarded as a mechanical factor for bone remodeling. However, whether the hyperosmotic stimulus affects 1alpha, 25-dihydroxyvitamin D3 (1alpha,25(OH)2D3)-induced osteoclastogenesis is not clear. In the present study, the effect of the hyperosmotic stimulus on 1alpha,25(OH)2D3-induced osteoclastogenesis was investigated in an osteoblast-preosteoclast co-culture system. Serial doses of sucrose were applied as a mechanical force. These hyperosmotic stimuli significantly evoked a reduced number of 1alpha,25(OH)2D3-induced tartrate-resistant acid phosphatase-positive multinucleated cells and 1alpha,25(OH)2D3-induced bone-resorbing pit area in a co-culture system. In osteoblastic cells, receptor activator of nuclear factor kappaB ligand (RANKL) and Runx2 expressions were down-regulated in response to 1alpha,25(OH)2D3. Knockdown of Runx2 inhibited 1alpha,25(OH)2D3-induced RANKL expression in osteoblastic cells. Finally, the hyperosmotic stimulus induced the overexpression of TonEBP in osteoblastic cells. These results suggest that hyperosmolarity leads to the down-regulation of 1alpha,25(OH)2D3-induced osteoclastogenesis, suppressing Runx2 and RANKL expression due to the TonEBP overexpression in osteoblastic cells.
Bone Remodeling
;
Coculture Techniques
;
Down-Regulation
;
Osteoblasts
;
RANK Ligand
;
Sucrose

Result Analysis
Print
Save
E-mail